DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,921,376 | +95.3% | 7,239 | +90.0% | 0.12% | +73.6% |
| Q3 2022 | $984,000 | -0.6% | 3,809 | -2.5% | 0.07% | +9.1% |
| Q2 2022 | $990,000 | +2.0% | 3,906 | +18.0% | 0.07% | +34.7% |
| Q1 2022 | $971,000 | -44.4% | 3,309 | -70.9% | 0.05% | -66.2% |
| Q4 2019 | $1,747,000 | +5.8% | 11,383 | -0.4% | 0.14% | -0.7% |
| Q3 2019 | $1,651,000 | +4.2% | 11,434 | +3.1% | 0.15% | -2.0% |
| Q2 2019 | $1,585,000 | +2.9% | 11,088 | -5.0% | 0.15% | +4.2% |
| Q1 2019 | $1,541,000 | +3.8% | 11,670 | -19.0% | 0.14% | +0.7% |
| Q4 2018 | $1,485,000 | -22.3% | 14,405 | -18.1% | 0.14% | -9.0% |
| Q3 2018 | $1,912,000 | +10.1% | 17,593 | 0.0% | 0.16% | -3.7% |
| Q2 2018 | $1,736,000 | +0.8% | 17,593 | 0.0% | 0.16% | +1.9% |
| Q1 2018 | $1,723,000 | +6.3% | 17,593 | +0.7% | 0.16% | -6.5% |
| Q4 2017 | $1,621,000 | +81.1% | 17,463 | +67.3% | 0.17% | +38.2% |
| Q3 2017 | $895,000 | +121.0% | 10,437 | +117.3% | 0.12% | +57.7% |
| Q2 2017 | $405,000 | +25.4% | 4,802 | +27.2% | 0.08% | +18.2% |
| Q1 2017 | $323,000 | +39.2% | 3,775 | +26.8% | 0.07% | +4.8% |
| Q4 2016 | $232,000 | – | 2,976 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |